Back

Intravenous iron therapy with ferric carboxymaltose results in a rapid and sustained rise in myocardial iron content through a non-canonical pathway: a translational study

11 May 2024 (08:42 - 08:50)
Organised by: Logo
Congress Presentation Part of: Late breaking clinical trials I Heart Failure HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Samira Lakhal-Littleton

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

9 More presentations in this session

Presentation thumbnail
Timing of Cardio-Kidney Protection with SGLT2 Inhibitors: Insights from Four Large-scale Placebo-Controlled Outcome Trials
Doctor M. Vaduganathan (Boston, US)
Slides Video
Presentation thumbnail
Discussant review - CANVAS Program, CREDENCE, DAPA-HF, and DELIVER
Professor M. Packer (Dallas, US)
Slides Video
Presentation thumbnail
Discussant review - IV iron and the heart
Professor E. Jankowska (Wroclaw, PL)
Slides Video
Presentation thumbnail
Impact of a remote monitoring program on all-cause mortality of patients with heart failure: National, real-world evidence of the TELESAT study
Professor N. Girerd (Nancy, FR)
Slides Video
Presentation thumbnail
Discussant review - TELESAT
Doctor M. Costanzo (Naperville, US)
Slides Video

Access the full session

Session thumbnail
Late breaking clinical trials I
Video

The Event

Event poster

Heart Failure 2024

11 May 2024 08:42 CET
You may be interested in
thumbnail
Congress Presentation
Iron metabolism in heart failure
thumbnail
Congress Presentation
Discussant review - IV iron and the heart
thumbnail
Congress Presentation
What about too much iron and heart failure?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources